Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Kihara James, Directeur Comptable. Officer active across 1 company, notably Acadia Pharmaceuticals INC. Cumulatively, 36 disclosures have been logged. Breakdown: 0 buy · 16 sells. Total volume traded: €509k. Activity tracked since 23 February 2022. The latest transaction was disclosed on 26 May 2026 (Cession). Regulator: SEC (Form 4). All data is free.
James Kihara is the Chief Accounting Officer at Acadia Pharmaceuticals Inc. He oversees the company's accounting and financial operations, ensuring compliance and integrity in financial reporting. His expertise in accounting is essential for managing Acadia's financial risks.